Peptide Purity vs. Net Content: Understanding the Difference

Purity and net content answer two different questions

A certificate of analysis for a research peptide usually carries two headline numbers. One is a percentage, typically in the high 90s. The other is a mass in milligrams, printed next to the label claim. They are easy to read as two versions of the same fact. They are not.

Chromatographic purity says what fraction of the peptide-related material the detector saw was the target compound rather than related impurities. It is a ratio of peak areas inside a chromatogram.

Net peptide content says how many milligrams of that peptide were in the vial. It is a quantity, measured against a reference standard and compared with what the label claims.

The Thymosin Alpha-1 10 mg certificate in our COA Library shows why the distinction matters: KMD Analytical reported 99.99 % chromatographic purity and 9.22 mg per vial against a 10 mg label, and both results conform to the laboratory's specifications. A reader who assumes purity describes quantity would expect 9.999 mg. The certificate says 9.22 mg, and explains on its face that purity "is not a measure of net peptide mass content". This article explains what each number measures, how laboratories arrive at them, why they diverge, and how to read them on single-compound and blended products.

What an HPLC purity percentage measures

High-performance liquid chromatography (HPLC) separates the components of a dissolved sample as they pass through a packed column; for peptides this is almost always reversed-phase chromatography on a C18 column with ultraviolet detection, most often at 214 nm, the wavelength at which the peptide backbone absorbs ^[1]. Each separated component produces a peak, and software integrates the area under every peak.

Chromatographic purity is then a simple ratio:

purity (area %) = area of the main peak ÷ sum of all integrated peak areas × 100

A result of 99.67 % means that 99.67 % of the integrated signal belonged to the main peak and 0.33 % belonged to everything else the method separated and the detector recorded. The number is sometimes written "area %" or "HPLC area %" on certificates for exactly this reason: it is a percentage of area, not of mass.

Three things follow from the definition:

• The denominator contains only what the detector responded to. Material that does not absorb at the detection wavelength, or that never eluted within the analysed window, is not counted.
• Related impurities that co-elute with the main peak are counted as main peak. Deletion sequences, diastereomers and oxidised variants are the usual synthesis-related impurities in peptides, and no single chromatographic method separates all of them ^[5]. European guidance therefore expects additional independent methods when one method cannot resolve the impurities, and treats co-eluting impurities as a single peak for threshold purposes ^[2].
• Different components can have different detector responses per unit mass. Area % assumes they are comparable, which is reasonable for peptide-related impurities at 214 nm but is an assumption all the same.

None of these limits makes purity a weak number. It is the right tool for the question it answers: how clean is the peptide material?

Why area percentage is not mass percentage

A lyophilised peptide vial contains more than peptide. The powder also holds counter-ions, water and residual solvent, and the vial holds whatever mass was dispensed into it. Purity ignores all four.

Counter-ions. Synthetic peptides are isolated as salts. The acid used in purification pairs with every basic site on the peptide, which means the free amino terminus plus any lysine, arginine or histidine side chains. Acetate is the usual counter-ion for peptide active substances, with trifluoroacetate and chloride also possible; regulators expect the type of counter-ion to be defined and its amount controlled in the specification ^[2], and trifluoroacetate left from purification can be exchanged for another counter-ion only by a deliberate additional step ^[9]. Counter-ions are not peaks in the peptide chromatogram, so a peptide can be 99.9 % pure by area while a measurable fraction of the powder's mass is salt rather than peptide.

Water. Peptides are often very hygroscopic powders, which is why guidance asks for water content as a specification parameter and for precautions against moisture uptake by reference standards during storage and analysis ^[2]. Water adds mass and contributes nothing to the chromatogram.

Residual solvent. Traces of solvents from synthesis and purification are controlled separately and, again, do not appear as peptide peaks ^[2].

Fill mass. A 10 mg label is a target for the amount of peptide dispensed. The actual mass in a given vial depends on the dispensing process, and purity cannot see it at all.

The regulatory convention makes the separation explicit: limits for assay by liquid chromatography are expressed in terms of the counter-ion-free, anhydrous substance ^[2]. In other words, the quantity of peptide is stated after stripping out salt and water, which is the opposite of what a purity percentage does.

That is why the KMD certificates in our library print a standing note beside the chromatogram: chromatographic purity "is not a measure of net peptide mass content (what fraction of the powder is peptide versus counter-ion, water, or residual solvent). That mass content is measured separately and reported above as content per vial."

What net peptide content is and how laboratories measure it

Net peptide content is the mass of the peptide itself in the vial. Regulatory guidance lists it as a separate specification attribute from purity, with its own test ^[4][2]. The methods laboratories use for it include:

The common thread is a comparison with something of known quantity. Quantitative HPLC, the method on most of our certificates, needs a reference standard whose own content is known; if the standard has absorbed water, the sample will read high, which is why guidance asks that the moisture content of a reference standard be confirmed before use or that a dissolved standard be used ^[2].

The measurement answers a different question from purity and can move independently of it. A vial can contain 9.22 mg of a 99.99 %-pure peptide against a 10 mg label, or 58.15 mg of a 99.88 %-pure peptide against a 50 mg label, and both certificates are internally consistent.

Label claim versus the amount the laboratory measured

The label claim is the quantity the supplier intends to fill. The measured content is what the laboratory found in the vial it opened. Certificates relate the two in one of three ways: as a percentage of claim with a pass criterion, as a per-vial value with a tolerance, or simply as a number beside the label. The table below is drawn from certificates in our library; every row is a different lot, tested by the laboratory named, and the certificate behind each row can be opened from the COA Library.

Four things stand out.

1. Purity sits in a narrow band; content does not. Every purity result in the table lies between 99.4 % and 99.99 %, while measured content runs from 92 % to 116 % of label. The two numbers are not tracking each other, because they do not measure the same thing.
2. Results above the label are as common as results below it. Overfill of a lyophilised vial is a dispensing outcome, not a purity outcome. GHK-Cu 50 mg at 58.15 mg against a 50 mg label and PPL-3RT 20 mg at 21.17 mg against a 20 mg label are both above the label; the Axiom result conforms to its ± 10 % tolerance, and the Freedom Diagnostics certificate prints no criterion for the reader to apply.
3. Each laboratory draws the pass line differently. KMD applies a one-sided floor (at least 90 % of claim). Axiom applies a two-sided tolerance per vial (within 10 % of the label) plus a consistency limit between vials. Kovera and Freedom Diagnostics print the result beside the label without a stated acceptance range, so the reader applies their own judgement.
4. Two certificates for the same product are two lots, not a disagreement. The PPL-3RT 20 mg rows (19.08 mg in July, 21.17 mg in October) and the Klow 80 mg rows (88.61 mg in July, 83.45 mg in October) were different lots tested months apart by different laboratories. They say nothing about either laboratory's accuracy relative to the other.

Why a material can be highly pure and still hold a different quantity

The two numbers are produced by different calculations on different inputs, so there is no mechanism that forces them to agree.

Take the Thymosin Alpha-1 vial above. The chromatogram shows essentially one peak, so purity is 99.99 %. The quantitative measurement compares that peak's size with a reference standard and finds 9.22 mg of peptide. The missing 0.78 mg against the label is not impurity; the purity figure already tells us impurities are a tiny fraction of the peptide material. It is some combination of fill mass below the target, counter-ion and water that count towards the powder's weight but not towards peptide, and the ordinary uncertainty of the measurement. The certificate cannot apportion the 0.78 mg among those causes, and does not try to.

The GHK-Cu 50 mg certificate makes the same point in the other direction: 99.88 % purity and a mean of 58.15 mg of peptide over two vials. Nothing about high purity constrains a vial to hold 50 mg.

For a researcher the practical consequence is straightforward. Purity tells you how much of what is in the vial is the right molecule. Net content tells you how much of the right molecule is there. Concentration calculations should start from the measured content on the certificate for the lot in hand, not from the label and not from the purity percentage; working from a 10 mg label when the lot measured 9.22 mg overstates the amount of peptide by about 8 %.

Limitations and uncertainty in both measurements

Every analytical result carries uncertainty. International guidance defines measurement uncertainty as a parameter characterising the dispersion of values that could reasonably be attributed to the measurand, and sets out how it is evaluated and expressed ^[8][7]. Research-material certificates rarely print an uncertainty figure, so the reader has to keep the main contributors in mind.

• Method performance. A validated quantitative method has demonstrated accuracy, precision, specificity, linearity and range for its purpose ^[3]. A certificate normally names the method and conditions but does not reproduce the validation data, so the stated result should be read as the method's best estimate, not an exact value.
• The reference standard. Quantitative HPLC is only as good as the standard it is calibrated against. If the standard's own content or moisture is off, every sample result shifts with it ^[2].
• Sample size. Many certificates test one vial; some test two. The Axiom PPL-3RT 20 mg certificate reports 21.10 mg and 21.24 mg with a coefficient of variation of 0.47 %, which is strong evidence of consistent fill between those two vials. The Freedom Diagnostics blend certificate reports 6.29 mg and 6.00 mg of BPC-157 in its two vials, a 4.7 % spread. A single-vial certificate cannot show spread at all. No research-material certificate attests to vials that were not sampled, and the laboratories say so: Axiom states that unless it performed or witnessed the sampling it does not attest that the sample represents the wider lot, and KMD states that results apply solely to the specific sample as received.
• Detector and wavelength. Area % purity depends on the detection wavelength and on the assumption of comparable response between the main peak and impurities. Certificates that state "214 nm" or "DAD" are telling you which assumption applies ^[1].
• What was not measured. A purity-and-content certificate says nothing about sterility, endotoxin, heavy metals or residual solvent unless those tests appear on it. KMD's certificates state this explicitly; Axiom's label each test by its validation status ("research screen", "validated in house", "verified compendial").
• Rounding and significant figures. A purity of 99.99 % reported to two decimals and 99.881 % reported to three are not more or less accurate because of the decimals shown; the precision of the method, not the formatting, sets the real resolution.

A result's meaning is the number together with its method, its sample size and its specification. Read alone, "99.99 %" and "9.22 mg" are incomplete.

How different laboratories report purity and content

The four laboratories whose certificates appear in our library report the same two attributes in visibly different formats. Knowing the format makes the certificates comparable.

Two consequences for the reader. First, "conforms" or "PASS" has to be read against the specification on that certificate: 92.2 % of claim passes KMD's floor of 90 %, and the same vial would also pass Axiom's ± 10 % tolerance, but neither statement transfers to a certificate that prints no criterion. Second, a per-vial format with mean, range and CV carries more information than a single number, because it shows how consistent the fill was in the vials actually opened.

Reading purity and content on multi-component blends

A blend certificate has to answer the two questions for each component, and the formats above handle that differently.

Content per component. Kovera's July 2026 certificate for Klow 80 mg lists each component against its labelled amount: GHK-Cu 55.84 mg against 50 mg, KPV 10.27 mg against 10 mg, BPC-157 11.58 mg against 10 mg and TB-500 (thymosin beta-4) 10.92 mg against 10 mg, summing to the 88.61 mg reported as blend net content. Freedom Diagnostics' certificate for BPC-157 + TB-500 10 mg reports BPC-157 and thymosin beta-4 separately in each of two vials, with means of 6.14 mg and 6.49 mg; the certificate prints no combined total, and the 12.63 mg shown in our library for that entry is the sum of the two component means. Per-component reporting is the only way to confirm that a blend contains each peptide in roughly the labelled proportion; a single total could hide a blend that is short of one component and long on another.

Purity per component or as a blend figure. Axiom's October 2026 certificate for Klow 80 mg, lot PPL-2610-KLOW, reports purity per declared component (means of 99.91 %, 99.6 %, 99.54 % and 99.62 % over two vials) and a headline figure of 99.67 %, with net peptide content reported as a mean of 83.45 mg over two vials and a container-to-container consistency check for every component (coefficients of variation from 0.27 % to 3.29 %). Kovera reports a single "Blend Avg Purity" of 99.881 %. Both are legitimate summaries, but they are not the same statistic, and the per-component version tells you more.

Identity per component. On a blend, identity has to be confirmed for every declared peptide. Axiom reports an accurate-mass match within ± 1 Da for each of the four Klow components, and a separate intact-complex measurement for GHK-Cu because the copper complex is the species of interest. Mass spectrometry coupled to liquid chromatography is the technique the analytical literature points to for confirming peptide identity ^[6]; a blend certificate that reports a single identity line for the mixture is weaker evidence than one that confirms each component.

Where to find these numbers at Precise Pep Labs

Every active product's certificates are listed in the COA Library, grouped by product and size, with the reported purity and net content shown beside each entry and a link to the laboratory's document. Each product page links to the certificate for the lot currently shipping, which is identified by the product's inventory batch number. Earlier certificates stay available under "Previous COAs" so lots can be compared over time.

For a field-by-field walk through a certificate, including identity evidence, lot numbers, dates and the laboratories' own caveats, see How to Read a Peptide Certificate of Analysis. When a lot on a vial does not appear in the library, contact us with the lot number before relying on the material.

Precise Pep Labs sells these materials for in vitro research use only. The certificates describe the samples tested; they are not a determination of suitability for any use.